BDX Becton Dickinson and Company

$195.69

*Only the 1D chart reflects 15-min delayed quotes during market hours. Other timeframes update after market close.

Reporting for fiscal period ending 2025-12-31
Expected on Jan 29, 2026
Report Time: Unknown Release Time
The Whisper Number
$3.02
Consensus Estimate: $2.81
Revenue Estimate: $5.15B

Latest Earnings Insight

In the upcoming earnings report for Becton Dickinson (BDX), investors are keenly focused on the company's ability to surpass expectations, particularly in light of the whisper number suggesting an EPS of $4.28, which exceeds the official estimate of $3.92. This indicates a strong market sentiment that Becton Dickinson might outperform its projected earnings. With a substantial market cap of approximately $52.8 billion, the company is poised to leverage its scale and operational efficiencies to potentially exceed the revenue estimate of $5.90 billion. As a leader in the medical technology sector, Becton Dickinson's strategic initiatives in expanding its product portfolio and enhancing global distribution networks could play a pivotal role in driving growth. Investors will be watching closely to see if these efforts translate into tangible financial gains, setting the stage for a robust performance in the upcoming earnings announcement on November 6, 2025.

Updated On 1/6/2026

About Becton Dickinson and Company

Becton, Dickinson and Company, also known as BD, is an American multinational medical technology company that manufactures and sells medical devices, instrument systems, and reagents. BD also provides consulting and analytics services in certain geographies.

Website: https://www.bd.com

Sector
LIFE SCIENCES
Industry
SURGICAL & MEDICAL INSTRUMENTS & APPARATUS
Exchange
NYSE
Country
USA
Currency
USD
Fiscal Year End
September
CIK
10795
Address
ONE BECTON DR, FRANKLIN LAKES, NJ, US
Valuation
Market Cap
$57.06B
P/E Ratio
33.45
PEG Ratio
0.91
Price to Book
2.26
Performance
EPS
$5.94
Dividend Yield
2.00%
Profit Margin
8.37%
ROE
6.84%
Technicals
50D MA
$222.46
200D MA
$230.87
52W High
$250.85
52W Low
$193.03
Fundamentals
Shares Outstanding
287M
Target Price
$275.03
Beta
0.38

BDX EPS Estimates vs Actual

Estimated
Actual

BDX News & Sentiment

Dec 31, 2025 • MarketBeat SOMEWHAT-BULLISH
Cwm LLC Grows Stock Holdings in Becton, Dickinson and Company $BDX
Cwm LLC significantly increased its holdings in Becton, Dickinson and Company (NYSE:BDX) by 69.1% in the third quarter, bringing their total to 38,205 shares valued at $7.15 million. This move is part of a broader trend of institutional investors adjusting their stakes in the medical instruments supplier. The article also provides a financial overview of Becton, Dickinson and Company, including recent stock performance, dividend increases, and analyst ratings.
Dec 30, 2025 • Seeking Alpha SOMEWHAT-BULLISH
ICU Medical: Difficult Transition, A More Interesting Company (Upgrade) (NASDAQ:ICUI)
ICU Medical has transitioned from a difficult integration period towards focusing on growth and margin expansion, notably by divesting its low-margin IV solutions business and launching new products. This strategic shift is expected to improve gross margins to 43-45%, achieve sustained EBITDA margins over 20%, and support double-digit free cash flow growth for deleveraging. Despite low growth, the company's valuation based on discounted cash flow and margin leverage suggests a fair value in the $180s, making it an attractive option among small med-tech companies.
Dec 30, 2025 • MarketBeat SOMEWHAT-BULLISH
Fort Washington Investment Advisors Inc. OH Has $169.53 Million Stock Holdings in Becton, Dickinson and Company $BDX
Fort Washington Investment Advisors Inc. OH increased its holdings in Becton, Dickinson and Company (NYSE:BDX) by 2.0% in Q3, owning 905,757 shares valued at $169.53 million. This makes BDX its 23rd-largest holding, representing 0.9% of its portfolio. Becton, Dickinson also raised its quarterly dividend to $1.05 per share, resulting in an annualized dividend of $4.20 and a 2.2% yield.
Dec 30, 2025 • MarketBeat SOMEWHAT-BULLISH
Pacer Advisors Inc. Has $4.39 Million Stock Position in Becton, Dickinson and Company $BDX
Pacer Advisors Inc. significantly reduced its stake in Becton, Dickinson and Company (NYSE:BDX) by 26.8% in Q3, selling 8,593 shares but still holding 23,469 shares valued at approximately $4.39 million. Other institutional investors adjusted their holdings as well, with overall institutional ownership at 86.97%. BDX recently increased its quarterly dividend to $1.05 and analysts currently have a consensus "Hold" rating with an average price target of $205.64.
Dec 29, 2025 • MarketBeat NEUTRAL
Becton, Dickinson and Company (NYSE:BDX) EVP Sells $14,509.92 in Stock
Becton, Dickinson and Company's (NYSE:BDX) EVP Michael Feld sold 74 shares of company stock for $14,509.92 on December 26th, reducing his stake by 0.45%. This sale follows previous transactions in December and October. The company also increased its quarterly dividend to $1.05 per share, representing a 2.1% yield.
Dec 29, 2025 • Investing.com NEUTRAL
Feld, Becton Dickinson EVP, sells $14509 in stock
Michael Feld, Executive Vice President at Becton Dickinson & Co (NYSE:BDX), sold 74 shares of common stock for a total of $14,509. The sale was executed under a Rule 10b5-1 trading plan. Despite this insider transaction, Becton Dickinson has maintained dividend payments for 55 consecutive years and is scheduled to report earnings on January 29, 2026.
Sentiment Snapshot

Average Sentiment Score:

0.159
50 articles with scored sentiment

Overall Sentiment:

Bullish

BDX Reported Earnings

Aug 07, 2025
Jun 30, 2025 (Pre market)
0.28 Surprise
  • Reported EPS: $3.68
  • Estimate: $3.40
  • Whisper:
  • Surprise %: 8.2%
May 01, 2025
Mar 31, 2025 (Pre market)
0.07 Surprise
  • Reported EPS: $3.35
  • Estimate: $3.28
  • Whisper:
  • Surprise %: 2.1%
Feb 05, 2025
Dec 31, 2024 (Post market)
0.44 Surprise
  • Reported EPS: $3.43
  • Estimate: $2.99
  • Whisper:
  • Surprise %: 14.7%
Nov 07, 2024
Sep 30, 2024 (Pre market)
0.04 Surprise
  • Reported EPS: $3.81
  • Estimate: $3.77
  • Whisper:
  • Surprise %: 1.1%
Aug 01, 2024
Jun 30, 2024 (Pre market)
0.19 Surprise
  • Reported EPS: $3.50
  • Estimate: $3.31
  • Whisper:
  • Surprise %: 5.7%
May 02, 2024
Mar 31, 2024 (Pre market)
0.2 Surprise
  • Reported EPS: $3.17
  • Estimate: $2.97
  • Whisper:
  • Surprise %: 6.7%
Feb 01, 2024
Dec 31, 2023 (Pre market)
0.28 Surprise
  • Reported EPS: $2.68
  • Estimate: $2.40
  • Whisper:
  • Surprise %: 11.7%
Nov 09, 2023
Sep 30, 2023 (Pre market)
-0.01 Surprise
  • Reported EPS: $3.42
  • Estimate: $3.43
  • Whisper:
  • Surprise %: -0.3%
Aug 03, 2023
Jun 30, 2023 (Pre market)
0.05 Surprise
  • Reported EPS: $2.96
  • Estimate: $2.91
  • Whisper:
  • Surprise %: 1.7%

Financials